Introduction {#Sec1}
============

Health literacy (HL) has become an increasingly important skill of citizens for health relevant decisions in modern societies. In addition, navigation in modern health care systems gets more and more complex for patients (Kickbusch et al. [@CR11]; Nielsen-Bohlman et al. [@CR16]; Nutbeam [@CR18]).

According to Nutbeam ([@CR18]) HL comprises three levels: (1) Basic/functional HL (i.e., sufficient basic reading and writing skills), (2) interactive HL (i.e., ability to extract health relevant information and derive meaning from different forms of communication), (3) critical HL (i.e., more advanced skills to critically analyse health relevant information and to use it for health decisions). Measures of HL cover health-related knowledge, attitudes, motivation, behavioral intentions, personal skills and self efficacy (Nutbeam [@CR18]).

More research has been done to assess the association of limited HL with health/social outcomes (Kondilis et al. [@CR13]). There is convincing evidence that limited HL is more prevalent in specific risk groups (such as low education groups) and is associated with poorer health/social outcomes and specific patterns of health care service use (DeWalt et al. [@CR5]; Rudd et al. [@CR23]).

Little is known, however, about the economic implications of limited HL on the health system. In addition, HL-data have most often been derived from US health care setting and transferability to other countries is unclear.

In this paper, we aim to systematically review the economic implications of limited HL by collecting evidence about the costs of limited HL and the cost-effectiveness of interventions to improve limited HL. Two research questions guided this systematic review: (1) What are the costs associated with limited HL. (2) What is the cost-effectiveness of interventions to improve HL?

Methods {#Sec2}
=======

We performed a systematic review in accordance with current guidelines (Drummond et al. [@CR6]; NHS Centre for Reviews and Dissemination [@CR15]). For methodological advice, we conducted a preliminary expert workshop of Swiss and international HL experts.

HL is generated in the society as a whole, i.e., in different societal areas (Kickbusch et al. [@CR11]; Nielsen-Bohlman et al. [@CR16]). HL may be generated in a private context (e.g., via educational learning in the family) or in the public environment (e.g., via health promotion programmes in schools) leading to improved HL in a broader sense. In addition, HL may be generated in the health care system for patients (via traditional patient education or patient self management programmes) leading to improved "Patient Literacy" (Table [1](#Tab1){ref-type="table"}). We applied this concept in our review by grouping retrieved studies to either a "Culture and society" category (such as Personal and community health, Adult education, HL friendly environments) or to the "Health care system" category (such as Patient education, Patient self management).Table 1Framework for health literacy (HL) interventions (adopted from Kirsch et al. [@CR12])SectorPopulationInterventionOutcomeHL level (Nutbeam (Nutbeam [@CR18]))*Culture and society* (personal health; community; workplace; consumer behavior; health politics)Persons from the general population (i.e., interventions not specifically addressing patients from the health care system)Health promotion interventions"Health literacy"Functional HL(to be applied for health decisions in daily life settings; the pre-requisite for "Patient Literacy")Interactive HLCritical HL*Health care system*Patients (e.g., persons with diabetes or cancer)Health promotion interventionsHealth literacy in the sense of "Patient Literacy"Functional HL(to be applied by patients for health decisions regarding the underlying disease)Interactive HLCritical HL

We applied an existing outcome model for health promotion (Gesundheitsförderung Schweiz [@CR8]; Nutbeam [@CR18]). According to this model, health promotion interventions (e.g., personal development programmes) may lead to (1) improved HL. Improved HL may then lead to (2) improved intermediate health outcomes (e.g., healthy life styles) and, finally, to (3) improved health outcomes (e.g., reduced morbidity or improved health-related quality of life). We applied this outcome model in our review as follows: as the focus was on HL, included studies had to report HL-outcomes (additional intermediate or final outcomes were possible). Studies reporting only about intermediate or final outcomes, without HL-information, were excluded.

Data sources {#Sec3}
------------

We systematically searched electronic databases for studies (Medline, Embase, the Cochrane library, PsychInfo, CINHAL; from 1980 through January 2008; no language restriction; see [Appendix 1](#Sec12){ref-type="sec"} for search strategy). In addition, we screened databases specialized in economic evaluations (NHS-Economic Evaluation Database) or HL (Harvard School of Public Health \[Health Literacy Studies\]); National Library of Medicine \[Current Bibliographies in Medicine, 2004-1\]; Agency for Healthcare Research and Quality \[Health Literacy and Cultural competency\]. Furthermore, we screened selected books and reference lists, performed Internet searches and contacted experts. All references were stored in an EndNote X.1 database (Thomson/ISI ResearchSoft Berkeley, CA, USA).

To be included, observational studies assessing the costs of limited HL had to report about all of the following items: prevalence of limited HL (as a base for cost calculations); health/social consequences of limited HL (such as service use or morbidity); and costs of limited HL in money terms. Studies assessing the prevalence of HL levels on a population level (without health/social consequences or cost data) were included, as well, to provide information on measurement methods for HL and on the budget impact of results of cost of illness studies.

To be included, interventional studies assessing cost-effectiveness had to report about all of the following items: interventions directed at HL; HL-outcomes (or HL-components such as knowledge, attitudes, or skills; additional intermediate or final outcomes were possible); and costs \[i.e., full economic evaluations that jointly compared costs and effects on HL of two or more alternatives (Drummond et al. [@CR6])\].

For interventional studies, we included population groups with limited HL (as measured with established instruments) or groups known to be at high risk for limited HL (such as minority groups, elderly persons, or low education populations) (Rudd et al. [@CR24]). We concentrated on such groups, as HL-interventions are expected to be most likely cost-effective in populations with the biggest need for improvement. In addition, this allows collecting evidence in intervention fields, where future programmes will probably be implemented.

To collect evidence about interventions directed at "Patient Literacy" in the health care system (according to our HL-framework; Table [1](#Tab1){ref-type="table"}), we included patients with two health problems (irrespective of the patients' HL-level, as it is specifically difficult to navigate and take health decisions in this expert oriented system for almost every patient): (1) Patients with diabetes mellitus and (2) patients with hyperlipidemia with established cardiovascular disease (i.e., secondary prevention indication). Our reasons to concentrate on two selected patient groups were as follows: First, a body of evidence already exists about traditional education programmes (as for hypertension or asthma therapy). To review this amount of literature would not be realistic for practical reasons. Second, the two selected health problems are of particular relevance due to their economic impact in the health care system. If interventions, directed at limited HL of such persons, were cost-effective, this might have relevant impact.

We excluded studies if interventions were directed at the general population (i.e., not targeting specific risk groups) or at patient groups with main health problems other than diabetes mellitus or hyperlipidemia (such as asthma). We included studies from developed countries (USA, Canada, Europe, Australia, New Zealand). We excluded reports from developing countries (with focus on poor basic Literacy skills), grey literature, editorials, and abstracts. These criteria were defined in advance and applied for all steps of inclusion assessment.

Data extraction and quality assessment {#Sec4}
--------------------------------------

One reviewer screened titles and abstracts for relevance using a predefined form. Unclear cases were discussed with a second reviewer. Disagreements were resolved by consensus. To enhance reliability of the screening process, training sessions were held in advance and agreement was assessed in a random sample, using chance-adjusted kappa statistics. Agreement between reviewers was high (Kappa 0.86). Potentially relevant studies were ordered and assessed for inclusion by full text.

Data were extracted by one reviewer on data extraction forms and checked independently by a second reviewer. We extracted data on general study information (such as study design, definition of HL), study setting (e.g., level of population recruitment), population details (e.g., age, ethnicity), outcome (e.g., definition of low HL, HL-outcome, intermediate outcome), and cost information (e.g., description of currency, cost date, discounting).

We performed a quality assessment using selected criteria of methodological standards for health-economic studies (Berkman et al. [@CR2]; Drummond et al. [@CR6]; NHS Centre for Reviews and Dissemination [@CR15]; Pignone et al. [@CR21]). We covered aspects of internal and external validity (such as description of population recruitment; description of outcome measurement for HL; or description of cost measurement; for details of quality assessment items see [Appendix 2](#Sec12){ref-type="sec"}).

Analysis {#Sec5}
--------

We present the included studies in a tabulated form. Due to considerable methodological heterogeneity between studies, no data pooling was possible. Major obstacles to pooling were diverse measurement tools and thresholds for limited HL as well as varying cost reporting and applied assumptions; minor obstacles were differences in description of study populations. The presentation format allows for a systematic overview on study characteristics to judge similarities and differences between studies.

Results {#Sec6}
=======

Our searches retrieved 2,340 potentially relevant studies (Fig. [1](#Fig1){ref-type="fig"}). We selected 72 studies that assessed either the prevalence of limited HL, the costs of limited HL or interventions to improve limited HL. Of those 72 studies, we excluded 22 interventional studies as they did not address the defined risk populations or did not report HL-outcomes and further 40 studies that assessed the effectiveness of interventions to improve limited HL but did not provide sufficient economic data.Fig. 1Study flow of the systematic review

The remaining ten studies were included for analysis. Of those ten studies, four reported prevalence data of limited HL in different populations (Kirsch et al. [@CR12]; Kutner et al. [@CR14]; OECD [@CR4]; Rudd et al. [@CR24]) and six studies (Friedland [@CR7]; Howard et al. [@CR9]; Sanders et al. [@CR26]; Spycher [@CR27]; Vernon et al. [@CR28]; Weiss and Palmer [@CR29]) assessed the costs of limited HL. No study reported cost-effectiveness data according to our inclusion criteria.

Costs of limited health literacy {#Sec7}
--------------------------------

We first report prevalence data that was applied in some of the included cost studies. Four studies (Kirsch et al. [@CR12]; Kutner et al. [@CR14]; OECD [@CR4]; Rudd et al. [@CR24]) provided data for the prevalence of limited HL in different populations (Table [2](#Tab2){ref-type="table"}). The prevalence studies include data of more than 110,000 participants from nationally representative samples. Data most often represent the US population \[1992 National Adult Literacy Survey, NALS (Kirsch et al. [@CR12]); 2003 National Assessment of Adult Literacy, NAAL (Kutner et al. [@CR14]); 2003 Adult Literacy and Life Skills Survey, ALL (OECD [@CR4]); 2004 Health Activities Literacy Scale, HALS (Rudd et al. [@CR24])\]. The 2003 Adult Literacy and Life Skills Survey also provides data for Norway, Italy, Canada, Bermuda, Mexico and Switzerland. Besides the US data, we have also extracted the information for the Swiss population.Table 2Prevalence of limited health literacy (HL) in different populationsAuthor, YearSurvey, start data collectionLocation of study, sample size, *n*Participation rateMeasurement of HL, definition of HL levelsPrevalence of limited HLQ-items^a^ (Yes/No/unclear)CommentsKirsch et al. [@CR12]National Adult Literacy Survey (NALS), 1992United States, *n* = 26,091NAScores along three scales of skills in prose, document, and quantitative Literacy21% NALS level1 (prose)3/1/0Additional results for subgroups provided(final score levels for each skill: NALS levels 1 \[low\] to 5 \[high\])23% NALS level1 (document)22% NALS level1 (quantitative)27% NALS level2 (prose)28% NALS level2 (document)25% NALS level2 (quantitative)Kutner et al. [@CR14]National Assessment of Adult Literacy (NAAL), 2003United States, *n* = 19,714Response rate 62% (results were published after "bias adjustment")Scores along three scales of skills in prose, document, and quantitative Literacy14% NAAL level1 (prose)4/0/0Some features of NAAL are different to NALS (e.g., different scoring definitions per class)(final score levels for each skill: NAAL level 1 \[below basic\]; level 2 \[basic\]; level 3 \[intermediate\]; 4 \[proficient\])12% NAAL level1 (document)NAAL offers a Health literacy Component (HLC); however, no figures are provided for HLC22% NAAL level1 (quantitative)29% NAAL level2 (prose)22% NAAL level2 (document)33% NAAL level2 (quantitative)OECD [@CR4]Adult Literacy and Life Skills Survey (ALL); Swiss data only, 2003Switzerland, *n* = 5,120Response rate 40% (unclear if "bias adjustment")Questionnaire; booklet with tasks of increasing difficultySwitzerland (level 1 and 2):3/1/0This data set contains only ALL data for Switzerland (additional countries in the ALL survey: Norway, Italy, US, Canada, Bermuda, Mexico)(level 1 and 2: low HL skills)52.2% (Prose Literacy)49.0% (document Literacy)39.3% (numeracy)66.1 (problem solving)OECD [@CR4]Adult Literacy and Life Skills Survey (ALL); US data only, 2003United States, *n* = 3,420Response rate 66% (unclear if "bias adjustment")Questionnaire; booklet with tasks of increasing difficultyUS (level 1 and 2):3/1/0This data set contains only ALL data for the US(level 1 and 2: low skills)52.6% (Prose Literacy)52.5% (document Literacy)58.6% (numeracy)(no data for problem solving)Rudd et al. [@CR24]Health Activities Literacy Scale (HALS); US data only, 1992United States, *n* = 58,000NA191 health-related items extracted from prevoius surveys (mostly NALS and IALS); after calibration procedure generation of 5 HL levels19% HALS level11/3/0HALS score was derived to measure HL for 5 health-related activities: Health promotion; health protection; disease prevention; health care & maintenance; systems navigation27% HALS level2A calibration procedure was applied to generate nearly identical mean values compared to NALS^a^ *Q-items* Quality items; applied scoring: Yes (number of fulfilled Q-items); No (number of Q-items that are not fulfilled); unclear (number of Q-items, for which information in the paper was not sufficient for judgement)

Methods for the measurement of HL differed between studies and often relied on basic/functional HL, sometimes on interactive or critical HL. While the 1992 NALS measured degrees of skills in prose, document, and quantitative Literacy, the 2004 HALS project measured five health-related activities (health promotion; health protection; disease prevention; health care and maintenance; systems navigation), that represent HL in a more complex form. The HALS instrument comprises 191 health-related items extracted from previous surveys (mostly from NALS and IALS). The definitions of limited HL varied between studies, too. Some measurement scales comprise five (Kirsch et al. [@CR12]; Rudd et al. [@CR24]), some four categories (Kutner et al. [@CR14]; OECD [@CR4]) to distinguish between people with low, intermediate or adequate HL.

Overall, the proportion of people with limited HL varied between 9 and 23% for the lowest HL level and between 34 and 59% if the two lowest HL levels were taken together. Comparing studies with five and four HL categories, the lowest figures for the lowest HL category alone (1/5 or 1/4) were 19 or 9%, and for the two lowest categories together (2/5 or 2/4) 46 or 34%.

Six studies (Friedland [@CR7]; Howard et al. [@CR9]; Sanders et al. [@CR26]; Spycher [@CR27]; Vernon et al. [@CR28]; Weiss and Palmer [@CR29]) provided data for the costs of limited HL, some of them relying on the prevalence data above (Table [3](#Tab3){ref-type="table"}). These studies include data of more than 54,000 participants. The cost studies most often applied data of selected US Medicaid or Medicare populations. Few individual patient data exist with HL-information and service cost data for the same person in one data set (Howard et al. [@CR9]). Thus, some authors have modeled the costs of persons with limited HL using assumptions (Friedland [@CR7]; Vernon et al. [@CR28]). Spycher ([@CR27]) has combined 2004 ALL Swiss prevalence data for limited HL with US cost data (also applying several assumptions) to provide a rough calculation for the costs of limited HL for Switzerland.Table 3Details of studies that assessed costs of limited health literacy (HL) in different populationsAuthor, YearLocation of study, sample size, *n* ethnicitySource of HL-prevalence (prev), source of costs (cost)OutcomeQ-items^a^ (Yes/no/unclear)CommentsPatient level/system levelHoward et al. [@CR9]United States, *n* = 3,260 US-American (76% White; 12% Black, 11% Hispanic, 1% other)Prev: Medicare HMO in 4 US locationsPatient level: additional costs of health service use for persons with low HL6/1/0Pop: Medicare HMO between 1996 and 1997 in 4 US locations. Participation rate 44% (3260/7471)Cost: from administrative claims dataWeiss and Palmer [@CR29]United States, *n* = 74 US-American (52% Hispanic; 37% Anglo; 9% other)Prev: Medicaid population (AHCCCS)Patient level: additional costs of participants with low reading levels; direct annual medical costs (mean annual total charges; mean annual inpatient charges)5/1/1This study is a reanalysis of a related paper (Weiss and Palmer [@CR29]) after exclusion of pregnant womenCost: health plan billing recordsPop: randomly selected indigent Medicaid population (AHCCCS)Sanders et al. [@CR26]United States, *n* = 290 US-American ethnic minority community (about 50% Black, about 50% Hispanic)Prev: for caregivers: own cross sectional data of HL (s-TOFHLA)Patient level: additional costs of health service use of children with inadequate (low) HL-caregivers compared to children with adequate (high) HL-caregivers3/2/2The study assessed the association between caregiver Health literacy and the use and cost of child health servicesCost: for children: Medicaid billing records; own hospital records for service useMedicaid cost data were only available for 139 children only (48% of 290 children). Recruitment of participants uncompletely describedFriedland [@CR7]United States, *n* = 26,091 US-AmericanPrev: NALS 1992 population dataSystem level: additional costs of health service use for persons with low HL4/2/1The final estimate was derived from predicted levels of functional Literacy and estimates of health care useCost: Health Care Financing Administration data: Survey of Income and Program Participation (SIPP) 1993Spycher [@CR27]Switzerland, *n* = 5,120 Swiss (German, French; Italian language)Prev: OECD [@CR4] Swiss population dataSystem level: additional costs of health service use for persons with low HL3/1/3The study applied modeling assumptions to US cost data to estimate the costs of low HL in SwitzerlandCost: National Academy on an Aging Society US 1998Vernon et al. [@CR28]United States, *n* = 19,714 US-AmericanPrev: NAAL 2003 population dataSystem level: additional costs of health service use for persons with low HL4/2/1The authors have adopted Friedland's 2002 assumptions and modeling methodology to guide their own calculationsCost: Medical Expenditure Panel Survey (MEPS) 2003^a^ *Q-items* Quality items; applied scoring: Yes (number of fulfilled Q-items); No (number of Q-items that are not fulfilled); unclear (number of Q-items, for which information in the paper was not sufficient for judgement)

The costs of limited HL are reported in two ways: Three studies (Friedland [@CR7]; Spycher [@CR27]; Vernon et al. [@CR28]) report the additional health care costs due to limited HL on the system level (Table [4](#Tab4){ref-type="table"}). According to these studies, the costs due to limited HL in the US or in Switzerland correspond to about 3--5% of the total health care spending \[upper bound for the US: 10% (Vernon et al. [@CR28])\].Table 4Costs of limited health literacy (HL) on the health care system levelAuthor, YearLocation of study, Sample size, *n*Costs due to low HL (system level)Currency, cost date, discountingTotal health care costs per year (system level)Estimated amount of health care costs per year attributable to low HLFriedland [@CR7]United States, *n* = 26,091US \$69 billion1996 US \$; no discountingNANA(US health care system)(NALS level1: \$29 billion)(NALS level1 + 2: \$69 billion)Spycher [@CR27]Switzerland, *n* = 5,120CHF 1.5 billion (Swiss health care system)2005 CHF; no discountingCHF 50 billion (in 2005)3%(ALL levels 1 + 2)Vernon et al. [@CR28]United States, *n* = 19,714US \$106--238 billion (US health care system)2003 US \$; with future discounting for infinite time horizon: US \$1.6--3.6 trillionUS \$2,300 billion (in 2007)4.6--10.3%(NAAL levels: basic + below basic)Estimated amount of health care costs per year attributable to low HL (for costs on the patient level see Fig. [2](#Fig2){ref-type="fig"})

Three other studies (Howard et al. [@CR9]; Sanders et al. [@CR26]; Weiss and Palmer [@CR29]) assessed additional costs due to limited HL on the patient level in selected populations. The amount of additional health care expenditures with limited HL compared to a reference group with adequate HL is in a range of \$143--7,798 per person per year (Fig. [2](#Fig2){ref-type="fig"}). Persons with low HL also showed a slightly increased use of inpatient and emergency room services (difference in probability: 0.05; 95%-CI: 0.00--0.10) and consumed an inefficient mix of health care services (Howard et al. [@CR9]).Fig. 2Costs of limited health literacy (HL) on the patient level. Differences in average annual health care costs per patient (for costs on the health care system level) (see Table [4](#Tab4){ref-type="table"}). Three studies are included in this plot. For each study two different outcome items are provided. Values on the left side of the indifference line indicate lower health care costs of persons with limited HL, values on the right side of the indifference line indicate higher health care costs of persons with limited HL compared to persons with adequate HL. If provided by the primary authors, a 95%-CI is added to the point estimates of each study

Cost-effectiveness of interventions to improve limited health literacy {#Sec8}
----------------------------------------------------------------------

We retrieved no study that jointly compared costs and HL-outcomes for two alternatives according to our inclusion criteria. For example, one excluded systematic review (Norris et al. [@CR17]) provided some information about the economic consequences to improve HL by patient self management programmes for diabetes, but only in relationship to clinical outcomes. Most primary studies with health-economic evaluations in this review failed to demonstrate effectiveness for the chosen clinical outcome, some studies only described the cost of intervention. In one study, the per-patient cost per unit improvement in glycemic control (as measured with HbA1c) was lower in the control group. No economic analyses in this review included indirect costs (productivity losses), no cost-benefit analyses were identified.

We did not retrieve studies from other sectors that assessed the cost-effectiveness of interventions to improve limited HL in specific risk groups (e.g., in workplace settings or for generation of HL-friendly environments in the community) (Kickbusch et al. [@CR11]).

Methodological quality {#Sec9}
----------------------

In general, the methodological quality of the included studies for this review was moderate to fair. Surveys for the estimation of population representative HL levels often used sophisticated sample selection criteria. However, measurement of HL was not standardized. Cost studies also varied in their methodological quality. While five of six studies reported population characteristics and recruitment of participants sufficiently well, only one study (Sanders et al. [@CR26]) described outcome measurement for service use in detail and only two (Howard et al. [@CR9]; Weiss and Palmer [@CR29]) of six studies described cost measurement in detail (e.g., quantities of resources use, currency and pricing date, discounting). None of the cost studies considered indirect costs. In addition, in all but one study (Sanders et al. [@CR26]), health care costs of children and adolescents that may also be influenced by low HL are not included and costs may be an underestimate.

Discussion {#Sec10}
==========

The additional costs of limited HL may be substantial (ranges per year: on the system level: 3--5% of the total health care cost; on the patient level: \$143--7,798 per person), but few studies were retrieved and the results are heterogenous. The evidence for the cost-effectiveness of interventions to improve limited HL is scarce.

To our knowledge, this is the first attempt to systematically summarize the economic impact of limited HL with a systematic review. We used a stepwise approach with implementation of an expert workshop, searches in electronic databases and inclusion of additional sources of information.

Our study has some limitations. First, the concept of HL is still under debate as well as methods for measurement of HL levels (Abel [@CR1]; Kickbusch [@CR10]). Therefore, we established an expert workshop in advance to discuss current methodological and conceptual problems in this area. Second, we may have missed relevant studies despite our attempts to retrieve further studies in addition to the electronic search results. Electronic retrieval of studies in the HL field is difficult. Authors sometimes do not (yet) use the term "health literacy" when they report about studies on improving knowledge or skills for daily health decisions. Third, the retrieved cost studies used solely data from the health care system. Little is known about the transferability of results to other societal areas, such as workplace settings. Finally, there is a substantial overlap between issues addressing HL and the area of health promotion/disease prevention. HL is seen as one key outcome of health promotion/disease prevention (Nutbeam [@CR18]). Thus, in a broader sense any health promotion/disease prevention intervention covers aspects of improving HL (such as improvement of knowledge, change of attitudes and development of skills). Even though HL is sometimes seen as an enabling factor to apply health promotion messages in daily life ("empowerment") (Nutbeam [@CR18]), the distinction between the two areas is not always clear. Therefore, in order not to replicate existing research about the cost-effectiveness of health promotion/disease prevention interventions (Brügger et al. [@CR3]; Rush et al. [@CR25]), we concentrated on studies that explicitly covered issues of limited HL \[i.e., HL (or its components) was conceptualized and measured in risk groups\].

To our knowledge, no systematic review has so far assessed the economic impact of limited HL on the health care system- or the patient level. However, comparison data exist for the prevalence of limited HL in patient populations. One systematic review (Paasche-Orlow et al. [@CR19]) assessed studies that examined the prevalence of limited HL specifically related to US health care or health services inquiries. The pooled weighted prevalence was 26% for low HL and 20% for marginal HL. Though that review did not provide nationally representative prevalence data, its estimates fit well with the prevalence data collected in our review.

The findings have serious implications for health policy. A considerable proportion of the assessed populations is deemed to have a HL level below the threshold considered to be adequate for increasingly difficult health-related tasks in the information society. Low HL is not only restricted to typical risk groups (such as ethnic minorities or migrants). A relevant part of inborn, native speakers is functionally illiterate with respect to health knowledge, health information retrieval, or performance of simple health-related problem solving (Rudd et al. [@CR24]). Problems that may grow as electronic information sources (e.g., the internet or electronic decision aids) will be increasingly important for daily health decisions, as well as in the health care system (Parker et al. [@CR20]).

Health care system reforms are urgently needed to improve communication and decision making between providers and patients. In addition, organisational development in the health care system is required to enable persons with low HL to navigate in HL-friendly environments (Rudd [@CR22]).

Societal areas beyond the health care system may play an even bigger role in tackling low HL in the society as a whole. This applies to the educational sector (with adult educational programmes; school based interventions), workplace settings (with specifically tailored health promotion interventions) or family based programmes for ethnic minority groups.

However, little evidence is available if interventions that aim to improve HL in citizens/patients will reduce service costs or are cost-effective on a societal perspective. Two scenarios are possible: on one hand, persons who gain improved skills to retrieve updated health information might behave like uncritical "health care consumers". Thus, they may show a greater demand for any new, apparently more effective and save, but also more expensive services. If such a trend takes place, it may be unlikely that the health care expenditures will decrease. On the other hand, interventions to improve HL might enable persons to critically check the supply on the health care market, to selectively choose services and, presumably more important, to take healthy decisions in their daily life settings (such as family, workplace, politics) (Kickbusch et al. [@CR11]). Such changes may contribute to lower health care costs of formerly low HL populations.

Based on the findings of our review we suggest some future research issues in the HL field: (1) Standardized, validated measurement tools that take account for the complex nature of HL. (2) Measurement of HL-level distribution on the population level with such instruments. This may allow for robust prevalence data. (3) Application of methodological standards for conduct and reporting of health-economic studies in the HL field. This may reduce bias of study results. For example, the two concordant cost studies (Howard et al. [@CR9]; Sanders et al. [@CR26]) with lower cost estimates included a potentially less needy population compared to the discrepant study of Weiss and Palmer ([@CR29]), as different instruments to categorize HL levels were applied. Sound health-economic studies, based on robust prevalence data, are most needed to address major impediments for data pooling (such as diversity in HL measurement tools, thresholds for limited HL, reporting of costs and model assumptions). (4) Observational studies to prospectively assess the association between HL and health care costs with individual patient data in health care settings with different organisational features and normative background. For example, employing US data for modeling in European health care settings with compulsory health care insurance may be problematic (Drummond et al. [@CR6]). Only one (Spycher [@CR27]) out of the six retrieved cost studies took place outside the United States. This study employed US cost data for modeling in an European (Swiss) health care setting with compulsory health care insurance. (5) Interventional studies to prospectively assess the cost-effectiveness of interventions to improve limited HL. (6) Continuous conceptual research to better understand the link between health promotion/disease prevention interventions and interventions designed to improve HL.

Conclusion {#Sec11}
==========

The costs of limited HL for the health care system may be substantial. However, results of cost studies are heterogeneous, relate to selected groups and studies show methodological shortcomings. More research is needed to better understand the economic aspects of limited HL and the cost-effectiveness of interventions to improve HL.

Appendix {#Sec12}
========

Appendix 1. Search strategyPubmed search strategy\#9Search \#4 AND \#5 Limits: Publication Date from 1980\#6Search \#4 AND \#5\#5Search Literacy \[TIAB\]\#4Search \#1 OR \#3\#3Search "Meta-Analysis"\[Publication Type\]\#1Search ("Economics"\[Mesh\]) OR ("economics"\[Subheading\]) OR ("Review"\[Publication Type\]) OR ("Clinical Trial"\[Publication Type\]) OR ("Comparative Study"\[Publication Type\]) OR (pre-post\[TIAB\]) OR ("pre-post"\[TIAB\]) OR ("before-after"\[TIAB\]) OR (before-after\[TIAB\]) OR (cost-effectiveness\[TIAB\]) OR ("cost-effectiveness"\[TIAB\]) OR ("cost-benefit"\[TIAB\]) OR (cost-benefit\[TIAB\]) OR ("cost of illness"\[TIAB\]) OR ("burden of disease"\[TIAB\])Cochrane search strategyIDSearchHitsEditDelete\#1(Economic\*):ti,ab,kw in Cochrane Reviews, Other Reviews, Clinical Trials, Technology Assessments and Economic Evaluations27966EditDelete\#2(Review):pt or (Clinical Trial):pt or (Controlled):pt or (Comparative Study):pt or (Meta-Analysis):pt in Cochrane Reviews, Other Reviews, Clinical Trials, Technology Assessments and Economic Evaluations308798EditDelete\#3(pre-post):ti,ab,kw or (before-after):ti,ab,kw or (cost-effectiveness):ti,ab,kw or (cost-benefit):ti,ab,kw in Cochrane Reviews, Other Reviews, Clinical Trials, Technology Assessments and Economic Evaluations15723EditDelete\#4"cost of illness":ti,ab,kw or "burden of disease":ti,ab,kw in Cochrane Reviews, Other Reviews, Clinical Trials, Technology Assessments and Economic Evaluations2660EditDelete\#5(\#1 OR \#2 OR \#3 OR \#4)333297EditDelete\#6(Literacy):ti,ab,kw in Cochrane Reviews, Other Reviews, Clinical Trials, Technology Assessments and Economic Evaluations171EditDelete\#7(\#5 AND \#6)132EditDelete\#8(\#7), from 1980 to 2008132EditDeleteAppendix 2. Applied quality items (Berkman et al. [@CR2]; Drummond et al. [@CR6]; NHS Centre for Reviews and Dissemination [@CR15]; Pignone et al. [@CR21])No.ItemsComment/criteriaPREVCOSTCEFF1 ext*Population characteristics* described in sufficient detail? (pop_sex_age_ethn_morb)At least 3: sex; age; morbidities or social features (such as ethnicity; education; income)PREVCOSTCEFF2 ext*Recruitment of population* described in sufficient detail? (site_level)Qual. description is sufficient;PREVCOSTCEFF3 ext*Intervention* described in sufficient detail? (intervention)CEFF4 ext*Alternative* described in sufficient detail? (alternative)CEFF5 int*Randomisation* procedure adequate? (gen of ran sequ; concealm of alloc)Both have to be described for randomised studiesCEFF6 int*Completeness* of follow up (follup_compl)Completeness fulfilled: \>=80%CEFF7 int*Blinding* (of outcome assessors or study analysts, may be for HL or costs)Fulfilled if stated in the textCEFF8 int*Outcome measurement for HL*: described in sufficient detail? (out_HL-meas)PREVCOSTCEFF9 int*Outcome measurement for intermed/final*: outcome described in sufficient detail? (out_cons)COSTCEFF10 int*Costs* measured correctly? (out_cost)To be described: quantities of resource use; currency and price date; discountingCOSTCEFF11 int*Outcome incremental analysis* for costs and consequences? (out_cost)CEFF12 ext*Perspective* of economic evaluation stated? (CEFF_persp)CEFF13 ext*Sensitivity analysis* performed? (CEFF_sensit)To address uncertainty of input variablesCOSTCEFF14 int*Analysis*: adequate techniques used?Measures of uncertainty for main results reported? (e.g. CI); accounted for confounding? (restriction; stratific.; multivar. models; ran) If econometric model used: time horizon stated?PREVCOSTCEFFApplied scoring: No; Yes; unclear*int* items addressing internal validity, *ext* items addressing external validity, *PREV* studies assessing the prevalence of HL levels, *COST* studies assessing the costs of limited HL, *CEFF* studies assessing the cost-effectiveness of interventions to improve limited HL
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